Skip to main content

Para negociar nos EUA, acesse polymarket.us

icon for Casos de sarampo nos EUA até 30 de setembro?

Casos de sarampo nos EUA até 30 de setembro?

icon for Casos de sarampo nos EUA até 30 de setembro?

Casos de sarampo nos EUA até 30 de setembro?

NOVO
30 set 2026
Polymarket

$6,865 Vol.

Polymarket

3800+

$134 Vol.

9%

4000+

$55 Vol.

28%

3200+

$1,957 Vol.

99%

3.300+

$172 Vol.

98%

3400+

$286 Vol.

98%

3500+

$633 Vol.

93%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**Sustained community transmission in multiple states, driven by large ongoing outbreaks in Pennsylvania, Ohio, and Wisconsin, is the main factor lifting 2026 U.S. measles totals.** As of September 3, the CDC reported 3,134 confirmed cases year-to-date—already far above 2025’s full-year record of 2,289—with 95% outbreak-linked and 94% occurring in unvaccinated or unknown-status individuals. The virus’s high contagiousness (airborne spread with R0 typically 12–18) and pockets of low MMR coverage sustain chains of transmission, while weekly case additions of roughly 100 in recent periods reflect active clusters. Official counts rely on laboratory-confirmed reports to state health departments and the CDC, subject to reporting lags and possible under-ascertainment. Key upcoming data points include the CDC’s next weekly update and state surveillance releases through late September that will determine final tallies by the 30th.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$6,865
Data de Término
1 out 2026
Mercado Aberto
Sep 1, 2026, 4:19 PM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**Sustained community transmission in multiple states, driven by large ongoing outbreaks in Pennsylvania, Ohio, and Wisconsin, is the main factor lifting 2026 U.S. measles totals.** As of September 3, the CDC reported 3,134 confirmed cases year-to-date—already far above 2025’s full-year record of 2,289—with 95% outbreak-linked and 94% occurring in unvaccinated or unknown-status individuals. The virus’s high contagiousness (airborne spread with R0 typically 12–18) and pockets of low MMR coverage sustain chains of transmission, while weekly case additions of roughly 100 in recent periods reflect active clusters. Official counts rely on laboratory-confirmed reports to state health departments and the CDC, subject to reporting lags and possible under-ascertainment. Key upcoming data points include the CDC’s next weekly update and state surveillance releases through late September that will determine final tallies by the 30th.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$6,865
Data de Término
1 out 2026
Mercado Aberto
Sep 1, 2026, 4:19 PM ET

Cuidado com os links externos.

Frequently Asked Questions

"Casos de sarampo nos EUA até 30 de setembro?" is a prediction market on Polymarket with 9 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "2900+" at 100%, followed by "3000+" at 100%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 100¢ implies that the market collectively assigns a 100% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

"Casos de sarampo nos EUA até 30 de setembro?" is a newly created market on Polymarket, launched on Aug 24, 2026. As an early market, this is your opportunity to be among the first traders to set the odds and establish the market's initial price signals. You can also bookmark this page to track volume and trading activity as the market gains traction over time.

To trade on "Casos de sarampo nos EUA até 30 de setembro?," browse the 9 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Casos de sarampo nos EUA até 30 de setembro?" is "2900+" at 100%, meaning the market assigns a 100% chance to that outcome. The next closest outcome is "3000+" at 100%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Casos de sarampo nos EUA até 30 de setembro?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.